CPX
ITRM

Canaan Partners X’s Iterum Therapeutics ITRM Stock Holding History

Canaan Partners X’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 3
2022
Q3 		– Sell
-115,545
Closed -$351K – 3
2022
Q2 		$346K Hold
115,545
– – 0.6% 3
2022
Q1 		$615K Hold
115,545
– – 0.62% 4
2021
Q4 		$679K Hold
115,545
– – 0.26% 4
2021
Q3 		$967K Hold
115,545
– – 0.28% 5
2021
Q2 		$4M Hold
115,545
– – 6.01% 3
2021
Q1 		$2.44M Hold
115,545
– – 3.33% 3
2020
Q4 		$1.71M Hold
115,545
– – 3.56% 3
2020
Q3 		$1.82M Hold
115,545
– – 3.62% 3
2020
Q2 		$2.06M Hold
115,545
– – 2.47% 3
2020
Q1 		$4.7M Hold
115,545
– – 5.17% 3
2019
Q4 		$7.8M Buy
+115,545
New +$5.64M 5.04% 3

Other funds holding ITRM

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.1B AUM 20.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $957M AUM 18.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return